WO2023215564 - BIOREACTOR SYSTEMS
National phase entry:
Publication Number
WO/2023/215564
Publication Date
09.11.2023
International Application No.
PCT/US2023/021167
International Filing Date
05.05.2023
Title **
[English]
BIOREACTOR SYSTEMS
[French]
SYSTÈMES DE BIORÉACTEURS
Applicants **
ABEC, INC.
Inventors
BOYCE, Christopher
KUBERA, Paul
LEIGHT, Nicholas
MILLER, Daniel
DYKE, Eric
Priority Data
63/339,124
06.05.2022
US
63/342,379
16.05.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2116 | |
| EPO | Filing, Examination, Granting | 8159 | |
| Japan | Filing, Examination, Granting | 2171 | |
| South Korea | Filing, Examination, Granting | 2084 | |
| USA | Filing, Examination, Granting | 7740 |
Total:
22,270
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
This disclosure relates to large-scale bioreactor systems comprising a vessel comprising internal reaction chamber having a volumetric and cell-sustaining capacity significantly above that of currently available bioreactor systems.[French]
La présente invention concerne des systèmes de bioréacteurs à grande échelle comprenant une cuve comprenant une chambre de réaction interne ayant une capacité volumétrique et de maintien de cellules significativement supérieure à celle des systèmes de bioréacteurs actuellement disponibles.